New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
D001205:Ascorbic Acid / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000628:therapy*; D009974:Orthomolecular Therapy
D007372:Interferons; D001205:Ascorbic Acid